BET降解剂在三阴性乳腺癌中表现出较低的抗增殖活性，机制为EGR1招募septins促进E2F1-3转录
BET degrader exhibits lower antiproliferative activity than its inhibitor via EGR1 recruiting septins to promote E2F1-3 transcription in triple-negative breast cancer
DOI 原文链接
用sci-hub下载
如无法下载，请从 Sci-Hub 选择可用站点尝试。
正在获取期刊数据...
发表日期:2024 Oct
作者:
DOI:10.1016/j.phrs.2024.107377
摘要
AI正在翻译并加载中文摘要...